{"id":54738,"date":"2022-07-22T08:05:43","date_gmt":"2022-07-22T13:05:43","guid":{"rendered":"https:\/\/www.partnershipagainstcancer.ca\/?post_type=corporate-documents&#038;p=54738"},"modified":"2025-07-23T15:04:06","modified_gmt":"2025-07-23T20:04:06","slug":"remuneration","status":"publish","type":"corporate-documents","link":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/","title":{"rendered":"R\u00e9mun\u00e9ration"},"content":{"rendered":"<p><strong>1.<\/strong> Les d\u00e9penses annuelles totales consacr\u00e9es \u00e0 la r\u00e9mun\u00e9ration vers\u00e9e au personnel permanent \u00e0 temps plein s\u2019\u00e9levaient \u00e0 17\u2009956\u2009073 $ pour l\u2019exercice clos le 31 d\u00e9cembre 2024.<\/p>\n<p><strong>2.<\/strong> Le nombre total de membres du personnel permanent \u00e0 temps plein au 31 mars 2025 \u00e9tait de 141. \u00c0 l\u2019occasion, le Partenariat fait appel \u00e0 du personnel contractuel pour g\u00e9rer la charge de travail.<\/p>\n<p><strong>3. Montant total de la r\u00e9mun\u00e9ration vers\u00e9e aux membres du personnel suivants pour l\u2019exercice clos le 31 d\u00e9cembre 2024 (tel que d\u00e9clar\u00e9 sur les feuillets T4 pour 2024) :<\/strong><\/p>\n<table class=\"table table-bordered\">\n<tbody>\n<tr class=\"active\">\n<th style=\"vertical-align: top;\" width=\"33%\"><strong>Titre <\/strong><\/th>\n<th style=\"vertical-align: top;\" width=\"33%\"><strong>R\u00e9mun\u00e9ration (feuillets T4 pour 2024)<\/strong><\/th>\n<th style=\"vertical-align: top;\" width=\"33%\"><strong>Avantages imposables (inclus dans le montant de la r\u00e9mun\u00e9ration)<\/strong><\/th>\n<\/tr>\n<\/tbody>\n<tbody>\n<tr>\n<td style=\"vertical-align: top;\" width=\"302\">Pr\u00e9sident-directeur g\u00e9n\u00e9ral<\/td>\n<td style=\"vertical-align: top;\" width=\"124\">735 742,66 $<\/td>\n<td style=\"vertical-align: top;\" width=\"160\">5 309,02 $<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"302\">Vice-pr\u00e9sidente, Syst\u00e8mes de lutte contre le cancer et innovation<\/td>\n<td style=\"vertical-align: top;\" width=\"124\">294 466,53 $<\/td>\n<td style=\"vertical-align: top;\" width=\"160\">4 111,44 $<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"302\"><\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"302\">Vice-pr\u00e9sident, Finances et services de l\u2019entreprise<\/td>\n<td style=\"vertical-align: top;\" width=\"124\">245 977,38 $<\/td>\n<td style=\"vertical-align: top;\" width=\"160\">4 651,40$<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"302\">Vice-pr\u00e9sidente, Partenariats strat\u00e9giques<\/td>\n<td style=\"vertical-align: top;\" width=\"124\">288 649,81 $<\/td>\n<td style=\"vertical-align: top;\" width=\"160\">4 809,02 $<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em><sup>*En 2023, la division de Lutte contre le cancer et la division des Syst\u00e8mes de lutte contre le cancer, du rendement et de l\u2019innovation ont fusionn\u00e9 pour former la division des Syst\u00e8mes de lutte contre le cancer et de l\u2019innovation<\/sup><\/em><\/p>\n<p><strong>4. <\/strong>Fourchettes salariales du personnel du Partenariat (en vigueur au 31 mars 2025) :<\/p>\n<table class=\"table table-bordered\">\n<tbody>\n<tr class=\"active\">\n<th style=\"vertical-align: top;\" width=\"10%\"><strong>Niveau<\/strong><\/th>\n<th style=\"vertical-align: top;\" width=\"40%\"><strong>Poste<\/strong><\/th>\n<th style=\"vertical-align: top;\" width=\"40%\"><strong>Fourchette de r\u00e9mun\u00e9ration annuelle<\/strong><\/th>\n<th style=\"vertical-align: top;\" width=\"10%\">Nombre de membres du personnel permanent \u00e0 temps plein<\/th>\n<\/tr>\n<\/tbody>\n<tbody>\n<tr>\n<td style=\"vertical-align: top;\" width=\"60\">9<\/td>\n<td style=\"vertical-align: top;\" width=\"264\">Directeur(-trice)<\/td>\n<td style=\"vertical-align: top;\" width=\"144\">131 895 $ \u00e0 202 753 $<\/td>\n<td style=\"vertical-align: top;\" width=\"118\">12<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"60\">7<\/td>\n<td style=\"vertical-align: top;\" width=\"264\">Gestionnaire, partenaire principal d\u2019affaires en RH, gestionnaire de programme, contr\u00f4leuse de gestion, responsable, architecte d\u2019entreprise<\/td>\n<td style=\"vertical-align: top;\" width=\"144\">100 780 $ \u00e0 138 721 $<\/td>\n<td style=\"vertical-align: top;\" width=\"118\">34<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"60\">6<\/td>\n<td style=\"vertical-align: top;\" width=\"264\">Analyste, gestionnaire de programme, gestionnaire de service, responsable, sp\u00e9cialiste, conseiller(-\u00e8re), comptable principal(e), d\u00e9veloppeur Web, gestionnaire de projet<\/td>\n<td style=\"vertical-align: top;\" width=\"144\">80 624 $ \u00e0 109 080 $<\/td>\n<td style=\"vertical-align: top;\" width=\"118\">64<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"60\">5<\/td>\n<td style=\"vertical-align: top;\" width=\"264\">Analyste, agent(e), adjointe de direction au pr\u00e9sident-directeur g\u00e9n\u00e9ral, adjointe de direction \u00e0 la vice-pr\u00e9sidente, Finances et services de l\u2019entreprise\/agente de liaison avec le conseil<\/td>\n<td style=\"vertical-align: top;\" width=\"144\">70 723 $ \u00e0 95 683 $<\/td>\n<td style=\"vertical-align: top;\" width=\"118\">11<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"60\">4b<\/td>\n<td style=\"vertical-align: top;\" width=\"264\">Adjoint(e) principal(e) de direction<\/td>\n<td style=\"vertical-align: top;\" width=\"144\">62 037 $ \u00e0 83 933 $<\/td>\n<td style=\"vertical-align: top;\" width=\"118\">1<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"60\">4<\/td>\n<td style=\"vertical-align: top;\" width=\"264\">Coordonnateur(-trice)<\/td>\n<td style=\"vertical-align: top;\" width=\"144\">54 419 $ \u00e0 73 626 $<\/td>\n<td style=\"vertical-align: top;\" width=\"118\">10<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"60\">3<\/td>\n<td style=\"vertical-align: top;\" width=\"264\">Adjoint(e) administratif(-ive)<\/td>\n<td style=\"vertical-align: top;\" width=\"144\">47 736 $ \u00e0 64 584 $<\/td>\n<td style=\"vertical-align: top;\" width=\"118\">6<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top;\" width=\"60\"><strong>\u00a0<\/strong><\/td>\n<td style=\"vertical-align: top;\" width=\"264\"><\/td>\n<td style=\"vertical-align: top;\" width=\"144\"><strong>T<\/strong><strong>OTAL<\/strong><\/td>\n<td style=\"vertical-align: top;\" width=\"118\"><strong>141*<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em><small>* Comprend 137 employ\u00e9s et 4 membres de la haute direction<\/small><\/em><\/p>\n<p><strong>5.<\/strong> Le montant total de la r\u00e9mun\u00e9ration vers\u00e9e aux membres du conseil d\u2019administration du Partenariat pour l\u2019exercice clos le 31 d\u00e9cembre 2024 (tel que d\u00e9clar\u00e9 \u00e0 l\u2019Agence du revenu du Canada sur les feuillets T4 pour 2024) s\u2019\u00e9levait \u00e0 130\u2009400 $.<\/p>\n<h3>R\u00e9mun\u00e9ration du Partenariat<\/h3>\n<ul>\n<li><a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2023-24\/\">R\u00e9mun\u00e9ration 2023-2024<\/a><\/li>\n<li><a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2022-23\/\">R\u00e9mun\u00e9ration 2022-2023<\/a><\/li>\n<li><a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2021-22\/\">R\u00e9mun\u00e9ration 2021-2022<\/a><\/li>\n<li><a href=\"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2021\/07\/Salary_Disclosure_2020-2021_FR.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9mun\u00e9ration 2020-2021<\/a><\/li>\n<li><a href=\"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2020\/08\/Compensation-FR.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9mun\u00e9ration 2019-2020<\/a><\/li>\n<li><a href=\"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2019\/07\/Disclosure_Document_FR.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9mun\u00e9ration 2018-2019<\/a><\/li>\n<li><a href=\"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2018\/08\/Salaries-and-Disclosure_Fre_Final.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9mun\u00e9ration 2017-2018<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>1. Les d\u00e9penses annuelles totales consacr\u00e9es \u00e0 la r\u00e9mun\u00e9ration vers\u00e9e au personnel permanent \u00e0 temps plein s\u2019\u00e9levaient \u00e0 17\u2009956\u2009073 $ pour l\u2019exercice clos le 31 d\u00e9cembre 2024. 2. Le nombre total de membres du personnel permanent \u00e0 temps plein au 31 mars 2025 \u00e9tait de 141. \u00c0 l\u2019occasion, le Partenariat fait appel \u00e0 du personnel [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":0,"menu_order":0,"template":"","corporate_documents_categories":[1038],"class_list":["post-54738","corporate-documents","type-corporate-documents","status-publish","hentry","corporate_documents_categories-performance-et-responsabilisation"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Canadian Partnership Against Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"R\u00e9mun\u00e9ration - Canadian Partnership Against Cancer\" \/>\n<meta property=\"og:description\" content=\"1. Les d\u00e9penses annuelles totales consacr\u00e9es \u00e0 la r\u00e9mun\u00e9ration vers\u00e9e au personnel permanent \u00e0 temps plein s\u2019\u00e9levaient \u00e0 17\u2009956\u2009073 $ pour l\u2019exercice clos le 31 d\u00e9cembre 2024. 2. Le nombre total de membres du personnel permanent \u00e0 temps plein au 31 mars 2025 \u00e9tait de 141. \u00c0 l\u2019occasion, le Partenariat fait appel \u00e0 du personnel [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Partnership Against Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-23T20:04:06+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cancerstratca\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/about-us\\\/corporate-strategic-document\\\/remuneration\\\/\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/about-us\\\/corporate-strategic-document\\\/remuneration\\\/\",\"name\":\"R\u00e9mun\u00e9ration - Canadian Partnership Against Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\"},\"datePublished\":\"2022-07-22T13:05:43+00:00\",\"dateModified\":\"2025-07-23T20:04:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/about-us\\\/corporate-strategic-document\\\/remuneration\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/about-us\\\/corporate-strategic-document\\\/remuneration\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/about-us\\\/corporate-strategic-document\\\/remuneration\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Corporate Documents\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/about-us\\\/corporate-strategic-document\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"R\u00e9mun\u00e9ration\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\",\"url\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/\",\"name\":\"Canadian Partnership Against Cancer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Partnership Against Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/","og_locale":"fr_FR","og_type":"article","og_title":"R\u00e9mun\u00e9ration - Canadian Partnership Against Cancer","og_description":"1. Les d\u00e9penses annuelles totales consacr\u00e9es \u00e0 la r\u00e9mun\u00e9ration vers\u00e9e au personnel permanent \u00e0 temps plein s\u2019\u00e9levaient \u00e0 17\u2009956\u2009073 $ pour l\u2019exercice clos le 31 d\u00e9cembre 2024. 2. Le nombre total de membres du personnel permanent \u00e0 temps plein au 31 mars 2025 \u00e9tait de 141. \u00c0 l\u2019occasion, le Partenariat fait appel \u00e0 du personnel [&hellip;]","og_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/","og_site_name":"Canadian Partnership Against Cancer","article_publisher":"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/","article_modified_time":"2025-07-23T20:04:06+00:00","twitter_card":"summary_large_image","twitter_site":"@cancerstratca","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/","url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/","name":"R\u00e9mun\u00e9ration - Canadian Partnership Against Cancer","isPartOf":{"@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website"},"datePublished":"2022-07-22T13:05:43+00:00","dateModified":"2025-07-23T20:04:06+00:00","breadcrumb":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Corporate Documents","item":"https:\/\/www.partnershipagainstcancer.ca\/about-us\/corporate-strategic-document\/"},{"@type":"ListItem","position":2,"name":"R\u00e9mun\u00e9ration"}]},{"@type":"WebSite","@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website","url":"https:\/\/dev.partnershipagainstcancer.ca\/","name":"Canadian Partnership Against Cancer","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.partnershipagainstcancer.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/corporate-documents\/54738","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/corporate-documents"}],"about":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/types\/corporate-documents"}],"author":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/users\/24"}],"wp:attachment":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=54738"}],"wp:term":[{"taxonomy":"corporate_documents_categories","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/corporate_documents_categories?post=54738"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}